Exagen Inc. (XGN) CEO Ron Rocca on Q3 2021 Results - Earnings Call Transcript

Nov. 13, 2021 12:48 PM ETExagen Inc. (XGN)
SA Transcripts profile picture
SA Transcripts
133.67K Followers

Exagen Inc. (NASDAQ:XGN) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET

Company Participants

Ryan Douglas - Investor Relations

Ron Rocca - President and Chief Executive Officer

Kamal Adawi - Chief Financial Officer

Conference Call Participants

Kyle Mikson - Canaccord Genuity

Paul Knight - KeyBanc Capital Markets

Operator

Good afternoon, and welcome to the Exagen Inc. Third Quarter 2021 Earnings Conference Call. [Operator Instructions]. Please note this event is being recorded.

I would now like to turn the conference over to Ryan Douglas and Mark Hazeltine, Investor Relations. Please go ahead.

Ryan Douglas

Good afternoon, and thank you for joining us today. Earlier today, Exagen Inc. released financial results for the quarter ended September 30, 2021. The release is currently available on the company's website at www.exagen.com.

Ron Rocca, President and Chief Executive Officer; Kamal Adawi, Chief Financial Officer; and Mark Hazeltine, Chief Operating Officer, will host this afternoon's call.

Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements.

All forward-looking statements, including, without limitation, statements regarding our business strategy and future financial and operating performance, including 2021 guidance, the impact of COVID-19 pandemic on our business, our current and future product offerings and reimbursement and coverage, are based upon current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.